The Treatment of Clavicular Fractures

NCT ID: NCT00642265

Last Updated: 2023-01-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2009-05-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with a displaced, shortened, midshaft clavicular fracture are randomized in two groups: conservative or operative treatment. The conservative arm is treated with a sling for 6 weeks. The operative arm is treated with osteosynthesis, within 2 weeks.

Patients are clinically and radiologically evaluated during 1 year. A economical analysis is also done.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Displaced, Midshaft Clavicular Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

operative treatment

Group Type EXPERIMENTAL

osteosynthesis

Intervention Type PROCEDURE

operative treatment

2

conservative treatment

Group Type ACTIVE_COMPARATOR

sling

Intervention Type OTHER

conservative treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

osteosynthesis

operative treatment

Intervention Type PROCEDURE

sling

conservative treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 to 65 year
* 100% displaced midshaft clavicular fracture
* shortening

* male: 18mm
* female: 14mm

Exclusion Criteria

* pregnancy
* pathological fracture
* open fracture
* history of frozen shoulder
* ipsilateral fracture of shoulder or scapula
* neurovascular injury
* contraindication to anaesthesia
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AZ Sint-Jan AV

OTHER

Sponsor Role collaborator

University Hospital, Ghent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lieven De Wilde, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Ghent

Bart Berghs, MD

Role: PRINCIPAL_INVESTIGATOR

AZ Sint-Jan AV

Pieter-Jan Vandekerckhove, MD

Role: PRINCIPAL_INVESTIGATOR

Sint-Andriesziekenhuis Tielt

J. Van Den Daele, MD

Role: PRINCIPAL_INVESTIGATOR

Stedelijk Ziekenhuis Roeselare

J. Vanonverschelde, MD

Role: PRINCIPAL_INVESTIGATOR

Stedelijk Ziekenhuis Aalst

G. Vandendriessche, MD

Role: PRINCIPAL_INVESTIGATOR

Jan Palfijnziekenhuis Ghent

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stedelijk Ziekenhuis Aalst

Aalst, , Belgium

Site Status

AZ Sint Jan-Brugge

Bruges, , Belgium

Site Status

Jan Palfijnziekenhuis

Ghent, , Belgium

Site Status

University Hospital Ghent

Ghent, , Belgium

Site Status

Stedelijk Ziekenhuis Roeselare

Roeselare, , Belgium

Site Status

Sint-Andries Ziekenhuis

Tielt, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2007/573

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Non Randomized Humerusshaft Fracture
NCT00205972 COMPLETED PHASE4
Study on Outcomes of Proximal Humerus Fractures
NCT07060664 NOT_YET_RECRUITING NA